Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma Using primary samples from the InterMEL study, a retrospective cohort of cases ...
Panagiotis A. Konstantinopoulos, MD, PhD; Elizabeth K. Lee, MD; Niya Xiong, MSc; Carolyn Krasner, MD; Susana Campos, MD, MPH; David L. Kolin, MD, PhD; Joyce F. Liu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results